Benzinga | Aug 5, 2020 05:04PM EDT

ResMed Q4 Adj. EPS $1.33 Beats $1.08 Estimate, Sales $770.30M Beat $746.90M Estimate

ResMed (NYSE:RMD) reported quarterly earnings of $1.33 per share which beat the analyst consensus estimate of $1.08 by 23.15 percent. This is a 40 percent increase over earnings of $0.95 per share from the same period last year. The company reported quarterly sales of $770.30 million which beat the analyst consensus estimate of $746.90 million by 3.13 percent. This is a 9.27 percent increase over sales of $704.96 million the same period last year.